LONDON, Feb 20 (Reuters) - Wyeth expects to launch Pristiq as a treatment for depression, even if nausea remains an issue for the medicine, its chief operating officer told Reuters on Tuesday. "Yes, ...
The newest entry in the antidepressant market is Pristiq (desvenlafaxine). It is pharmacologically classified as a serotonin norepinephrine reuptake inhibitor (SNRI) antidepressant, a medication ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback